BioCardia, Inc.
BCDA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $8,098 | $10 | $7 | $6 |
| - Cash | $5 | $1 | $1 | $2 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $8,094 | $10 | $7 | $5 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$1 | -$2 | -$1 |
| % Margin | – | – | – | – |
| EBITDA | -$1 | -$2 | -$3 | -$2 |
| % Margin | – | – | – | – |
| Net Income | -$1 | -$2 | -$3 | -$2 |
| % Margin | – | – | – | – |
| EPS Diluted | -236.23 | -0.4 | -0.99 | -0.5 |
| % Growth | -58,957.5% | 59.6% | -98% | – |
| Operating Cash Flow | -$2 | -$2 | -$2 | -$3 |
| Capital Expenditures | $0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$2 | -$2 | -$2 | -$3 |